8
Total investments
5
Early stage
1
Mid stage
0
Late stage
10y
Years active
Portfolio
7 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Seed Investor
Jul 2025
OneFlash is the guarantor of the digital experience.
By providing a mobile solution to the lack of battery power on smartphones, OneFlash enables all users to take full advantage of the digital tools developed by retailers.
Seed Investor
Apr 2022
Aujourd’hui, 25% de lempreinte carbone mondiale provient des échanges internationaux : ils génèrent énormément d’émissions pour trop peu d’actions mises en place.
Keewe, c’est la fintech pour des échanges internationaux plus simples et plus durables. On pense que l’action écologique ne doit pas être un coût à subir mais un avantage compétitif pour embarquer les entreprises.
On agit sur
- l’impact : on mesure l’empreinte carbone des opérations tout en générant de l’impact positif
- le prix : on est ultra compétitifs et transparents par rapport au marché bancaire et aux autres fintech
- la simplicité : c’est facile, intuitif. Tous les services financiers internationaux sont au même endroit.
Pour convaincre, on doit simplifier. L’impact ne doit pas être une charge supplémentaire. Les entreprises n’ont rien à faire: on est là pour accompagner.
____________________________________________________________________________
Lauréat de Scale up Excellence de la French Tech
Prix coup de ❤ du Challenge Fintech for Tomorrow 2019
Labellisé Envol! : https://www.envol-entreprise.fr/
Et accéléré par WILCO (https://www.wilco-startup.com/)
www.keewe.eu
PreSeed Investor
Apr 2021
We are building the first light, inexpensive MRI machine that works at an ultra-low magnetic field without compromising on image quality. Our mission is to profoundly transform healthcare by making MRI 100x more accessible, enabling wider, earlier, and massive screenings and check-ins. Many deadly diseases are already curable if diagnosed early enough: we are building a future in which MRI is as common as blood sampling.
PreSeed & Seed Investor
Nov 2020
At Kinetix, we combine deep AI expertise with advanced 3D animation technologies to shape the future of character motion. Leveraging extensive proprietary datasets and advanced synthetic data pipelines, we drive cutting-edge AI research to push the boundaries of how motion is created, understood, and applied across digital and physical worlds.
Learn more: https://www.kinetix.tech
Investor (BA)
May 2020
Creating trust whenever a car changes hands thanks to AI & computer vision anywhere in the World.
👁 🏎
Monk is an AI company delivering state of the art computer vision solutions for the automotive, insurance and mobility markets, bringing excellence, trust and transparency.
Our technology addresses every stage of the vehicle lifecycle:
We help Carsharing, DMS, Remarketing, Logistic, Car experts companies worldwide inspect and evaluate cars.
Our visual intelligence technology inspects and evaluates any car in the world.
We have a modular and open technological approach delivering our robust and nimble computer vision solutions through API, SDK and APP.
Follow our page and visit our website to test our AI powered inspection (http://www.monk.ai).
Investor (BA) & Board Member
May 2016
Created in February 2012, PEPS SA is a Marrakech based joint-venture between NST, a Guadeloupian company specialized in clean-tech development, and Imperium Holding, a Moroccan tier-1 industrial group.
PEPS International industrializes the Solar Micro-Wave process (SMO®) and develops its commercial expansion throughout the globe.
The SMO© processes waste, plastic and biomasses into a highly valuable output – electricity or activated charcoal – through a patented path of technological innovations, based on the solar pyrolysis principle.
The SMO® processes the recovery without GHG emission and energy-autonomously, while crystalizing most of the value locally.
With key features such as positive energy balance, mobility, adaptability and polyvalence, be it at the input (waste/biomass) or output (electricity/activated charcoal) level, the SMO® presents a highly competitive edge.
The prizes obtained for its innovative solutions, notably at the MASEN FT2M 2015 and the OCP Hackathon 2016 editions, have triggered significant media coverage and institutional traction for the SMO®.
NST and PEPS are respectively backed by i) the French BPI & the Conseil Régional de Guadeloupe and ii) the Cluster Solaire (MASEN) & the Conseil Régional de Marrakech-Safi.
Experience · 14 entries
All (14)
Investments (8)
Founder (2)
Board (3)
2025
Seed Investor
Jul 2025
OneFlash is the guarantor of the digital experience.
By providing a mobile solution to the lack of battery power on smartphones, OneFlash enables all users to take full advantage of the digital tools developed by retailers.
2024
Co-Founder & Chairman
Sep 2024
OcciCal Therapeutics est une start-up de biotechnologie basée en Occitanie, spécialisée dans le développement du premier traitement préventif contre la dysfonction diaphragmatique induite par la ventilation mécanique (VIDD), une pathologie méconnue mais d’une incidence significative. Chaque année, plus de 20 millions de patients sous assistance respiratoire sont à risque de développer cette dysfonction, qui altère gravement le pronostic vital et fonctionnel à long terme.
Notre programme de recherche repose sur les découvertes réalisées par le laboratoire PhyMedExp (INSERM-CNRS) et l’IBMM (CNRS), en collaboration avec l’Université de Montpellier et le CHU de Montpellier. Ce projet de R&D explore les mécanismes moléculaires et cellulaires sous-jacents à la VIDD, avec pour objectif de développer une approche thérapeutique innovante fondée sur l’utilisation d’oxylipines. Ces travaux visent à améliorer la gestion clinique des patients ventilés et à réduire la morbidité associée à la ventilation mécanique prolongée.
***
OcciCal Therapeutics is a biotechnology start-up based in Occitanie, specializing in the development of the first preventive treatment for ventilator-induced diaphragm dysfunction (VIDD), a little-known condition with a significant incidence. Each year, more than 20 million patients on respiratory support are at risk of developing this dysfunction, which severely impacts both long-term survival and functional prognosis.
Our research program is built on discoveries made by the PhyMedExp laboratory (INSERM-CNRS) and IBMM (CNRS), in collaboration with the University of Montpellier and Montpellier University Hospital. This R&D project investigates the molecular and cellular mechanisms underlying VIDD, aiming to develop an innovative therapeutic approach based on the use of oxylipins. The goal is to improve the clinical management of ventilated patients and reduce the morbidity associated with prolonged mechanical ventilation.
2022
Seed Investor
Apr 2022
Aujourd’hui, 25% de lempreinte carbone mondiale provient des échanges internationaux : ils génèrent énormément d’émissions pour trop peu d’actions mises en place.
Keewe, c’est la fintech pour des échanges internationaux plus simples et plus durables. On pense que l’action écologique ne doit pas être un coût à subir mais un avantage compétitif pour embarquer les entreprises.
On agit sur
- l’impact : on mesure l’empreinte carbone des opérations tout en générant de l’impact positif
- le prix : on est ultra compétitifs et transparents par rapport au marché bancaire et aux autres fintech
- la simplicité : c’est facile, intuitif. Tous les services financiers internationaux sont au même endroit.
Pour convaincre, on doit simplifier. L’impact ne doit pas être une charge supplémentaire. Les entreprises n’ont rien à faire: on est là pour accompagner.
____________________________________________________________________________
Lauréat de Scale up Excellence de la French Tech
Prix coup de ❤ du Challenge Fintech for Tomorrow 2019
Labellisé Envol! : https://www.envol-entreprise.fr/
Et accéléré par WILCO (https://www.wilco-startup.com/)
www.keewe.eu
2021
PreSeed Investor
Apr 2021
We are building the first light, inexpensive MRI machine that works at an ultra-low magnetic field without compromising on image quality. Our mission is to profoundly transform healthcare by making MRI 100x more accessible, enabling wider, earlier, and massive screenings and check-ins. Many deadly diseases are already curable if diagnosed early enough: we are building a future in which MRI is as common as blood sampling.
2020
PreSeed & Seed Investor
Nov 2020
At Kinetix, we combine deep AI expertise with advanced 3D animation technologies to shape the future of character motion. Leveraging extensive proprietary datasets and advanced synthetic data pipelines, we drive cutting-edge AI research to push the boundaries of how motion is created, understood, and applied across digital and physical worlds.
Learn more: https://www.kinetix.tech
Show all 14 entries ↓
Investment activity
2016–2025 · 8 investments
Recent (last 2 years)Earlier
